Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
92,034,159
-
Share change
-
-1,902,166
-
Total reported value
-
$7,632,271,781
-
Put/Call ratio
-
84%
-
Price per share
-
$82.93
-
Number of holders
-
258
-
Value change
-
-$152,719,450
-
Number of buys
-
132
-
Number of sells
-
115
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2018
As of 31 Mar 2018 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 258 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 92,034,159 shares of stock of the company.
Largest 10 holders included FMR LLC, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., PERCEPTIVE ADVISORS LLC, BB BIOTECH AG, Invesco Ltd., WELLINGTON MANAGEMENT GROUP LLP, and FRANKLIN RESOURCES INC.
This table shows 260 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.